Wuhan HealthCare Biotechnology
Wuhan HealthCare Biotechnology Co., Ltd. Building #8, Optics Valley Precision Medicine Industry Base, #9 Gaokeyuan 3rd Road, East Lake High-Tech Zone. 430206, Wuhan, Hubei, China. Tel#: +86(027)8757-0662 Ext. #812 E-mail: cs@healthcare-bio.com | Website: healthcare-biotech.com |
FISH Fast Probes List |
|||||
Diagnosis |
Cat. # |
Description |
Name |
Format |
Volume/Size |
Non-Small Cell Lung Cancer |
FP-002 |
ALK gene fusion detection probe |
ALK |
CE-IVD/RUO |
100μL/10 Tests |
FP-006 |
6q(ROS1) gene detection probe |
ROS1 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-046 |
MET gene detection probe |
C-MET/CEP7 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-082 |
MAML2(11q21) gene break apart detection probe |
MAML2 |
IVD/RUO |
100μL/10 Tests |
|
FP-231-1 |
NTRK1 gene break apart detection probe |
NTRK1 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-231-2 |
NTRK2(9q21) gene break apart detection probe |
NTRK2 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-231-3 |
NTRK3(15q25) gene break apart detection probe |
NTRK3 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-227 |
PDL1(9p24)/CSP9 gene amplification detection probe |
PD-L1/CEP9 |
IVD/RUO |
100μL/10 Tests |
|
Breast Cancer |
FP-001 |
HER2 gene amplification detection probe |
HER2/CEP17 |
CE-IVD/RUO |
100μL/10 Tests |
FP-008 |
TOP2A gene amplification detection probe |
TOP2A |
IVD/RUO |
100μL/10 Tests |
|
FP-083 |
ETV6/NTRK3 gene fusion t(12;15) detection probe |
ETV6/NTRK3 |
IVD/RUO |
100μL/10 Tests |
|
FP-041 |
CCND1(BCL1) gene amplification detection probe |
CCND1/CEP11 |
IVD/RUO |
100μL/10 Tests |
|
FP-203 |
EPOR(19p13) gene break apart detection probe |
EPOR |
IVD/RUO |
100μL/10 Tests |
|
Stomach Cancer |
FP-001 |
HER2 gene amplification detection probe |
HER2 |
CE-IVD/RUO |
100μL/10 Tests |
Bladder Cancer |
FP-009 |
Bladder Cancer Cells chromosome and gene anomaly detection probe |
CEP3/CEP7 ; P16/CEP17 |
CE-IVD/RUO |
200μL/10 Tests |
FP-014-2 |
CLL chromosome and gene anomaly detection probe |
P53/CEP17 |
CE-IVD/RUO |
100μL/10 Tests |
|
Cervical Cancer |
FP-013 |
TERC gene amplification detection probe |
TERC |
CE-IVD/RUO |
100μL/10 Tests |
Brain Cancer |
FP-045 |
1p/19q deletion detection probe |
1p/19q |
CE-IVD/RUO |
200μL/10 Tests |
FP-016 |
BRAF gene break apart detection probe |
BRAF |
CE-IVD/RUO |
100μL/10 Tests |
|
Lymphoma |
FP-243-2 |
MYC(8q24) ; BCL6(3q27) ; BCL2(18q21) gene break apart detection probe |
BCL6 |
CE-IVD/RUO |
100μL/10 Tests |
FP-243-3 |
MYC(8q24) ; BCL6(3q27) ; BCL2(18q21) gene break apart detection probe |
BCL2 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-242-3 |
BCL6 ; MYC ; IGH ; BCL2/IGH gene detection probe |
IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-234-3 |
MAFB/IGH ; CCND3/IGH ; MYC/IGH gene fusion detection probe |
IGH/C-MYC |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-242-4 |
BCL6 ; MYC ; IGH ; BCL2/IGH gene detection probe |
IGH/BCL2 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-014-2 |
CLL chromosome and gene anomaly detection probe |
P53/CEP17 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-243-1 |
MYC(8q24) ; BCL6(3q27) ; BCL2(18q21) gene break apart detection prob |
MYC |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-233-1 |
IGH/CCND1; IGH/MAF ; IGH/MAFB ; IGH/FGFR3 gene fusion detection probe |
CCND1/IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-158 |
MALT1 gene break apart detection probe |
MALT1 |
IVD/RUO |
100μL/10 Tests |
|
FP-159 |
MALT1/IGH gene fusion t(14; 18) detection probe |
MALT1/IGH |
IVD/RUO |
100μL/10 Tests |
|
FP-160 |
IRF4(6p25) gene break apart detection probe |
IRF4 |
IVD/RUO |
100μL/10 Tests |
|
FP-160 |
API2/MALT1 t(11;18) gene detection probe |
API2/MALT1 |
IVD/RUO |
100μL/10 Tests |
|
FP-164 |
11q23.3/11q24.3 gene deletion detection probe |
11q23.3/11q24.3 |
IVD/RUO |
100μL/10 Tests |
|
FP-227 |
PDL1(9p24)/CSP9 gene amplification detection probe |
PDL1/CEP9 |
IVD/RUO |
100μL/10 Tests |
|
Chronic Lymphocytic Leukemia (CLL) |
FP-014-1 |
CLL chromosome and gene anomaly detection probe |
RB1/ATM |
CE-IVD/RUO |
100μL/10 Tests |
FP-014-2 |
P53/CEP17 |
CE-IVD/RUO |
100μL/10 Tests |
||
FP-014-3 |
D13S319/CEP12 |
CE-IVD/RUO |
100μL/10 Tests |
||
FP-034 |
Chromosome 12 centromere detection probe |
CEP12 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-245-3 |
P53; CCND1/IGH ; CEP11/ATM ; CEP12/D13S25 gene detection probe |
CEP11/ATM |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-025 |
13(13q14) gene detection probe |
D13S319/LAMP1 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-036 |
MYB(6q23) gene detection probe |
MYB/CEP6 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-198 |
D13S25(13q14) gene deletion detection probe |
D13S25 |
IVD/RUO |
100μL/10 Tests |
|
FP-200 |
D13S319 gene deletion detection probe |
D13S319 |
IVD/RUO |
100μL/10 Tests |
|
Acute Myeloid Leukemia/AML (Non APL) |
FP-004 |
AML1/ETO gene fusion detection probe |
AML1/ETO |
CE-IVD/RUO |
100μL/10 Tests |
FP-005 |
RARA(17q21) detection probe |
PML/RARA |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-027 |
CBFB gene break apart detection probe |
CBFB |
IVD/RUO |
100μL/10 Tests |
|
FP-026 |
KMT2A(MLL) gene break apart detection probe |
MLL |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-028 |
CBFBMYH11gene fusion detection probe |
CBFB/MYH11 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-043 |
RARA gene break apart detection probe |
RARA |
IVD/RUO |
100μL/10 Tests |
|
FP-179 |
EVI gene break apart detection probe |
EVI1 |
CE-IVD/RUO |
100μL/10 Tests |
|
Chronic Myeloid Leukemia (CML) |
FP-003 |
BCRABL gene fusion detection probe |
BCR/ABL |
CE-IVD/RUO |
100μL/10 Tests |
FP-170 |
CHIC2 gene deletion (PDGFRA break) detection probe |
CHIC2(PDGFRA) |
IVD/RUO |
100μL/10 Tests |
|
FP-174 |
NUP98 gene break apart detection probe |
NUP98 |
IVD/RUO |
100μL/10 Tests |
|
FP-232-1 |
FGFR1 gene break apart detection probe |
FGFR1 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-232-2 |
PDGFRA ; PDGFRB gene break apart detection probe |
PDGFRA |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-230-5 |
ABL1 ; ABL2 ; PDGFRB ; CRLF2 ; JAK2 gene break apart detection probe |
JAK2 |
IVD/RUO |
100μL/10 Tests |
|
Acute Lymphoblastic Leukemia (ALL) |
FP-029 |
ETV6(TEL)/RUNX1(AML1) gene translocation detection probe |
TEL/AML1 |
CE-IVD/RUO |
100μL/10 Tests |
FP-003 |
BCRABL gene fusion detection probe |
BCR/ABL |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-242-3 |
BCL6 ; MYC ; IGH ; BCL2IGH gene detection probe |
IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-032 |
P16 gene deletion detection probe |
P16 (CDK2NA)/CEP9 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-026 |
KMT2A(MLL) gene break apart detection probe |
MLL |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-030 |
Chromosomes 4, 10 detection probe |
CEP4/CEP10 |
IVD/RUO |
100μL/10 Tests |
|
FP-031 |
Chromosome 17 centromeric detection probe |
CEP17 |
IVD/RUO |
100μL/10 Tests |
|
FP-243-1 |
MYC(8q24)/BCL6(3q27)/BCL2(18q21) gene break apart detection probe |
MYC |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-062 |
TCF3/PBX1 gene fusion detection probe |
TCF3/PBX1 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-230-4 |
ABL1 ; ABL2 ; PDGFRB ; CRLF2 ; JAK2 gene break apart detection probe |
CRLF2 |
IVD/RUO |
100μL/10 Tests |
|
FP-183 |
E2A gene break apart detection probe |
E2A |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-131 |
MLL gene deletion detection probe |
MLL/CEP11 |
IVD/RUO |
100μL/10 Tests |
|
FP-181 |
ETV6 gene break apart detection probe |
ETV6 |
IVD/RUO |
100μL/10 Tests |
|
FP-208 |
DEK/NUP214 gene fusion detection probe |
DEK/NUP214 |
IVD/RUO |
100μL/10 Tests |
|
FP-317 |
TCRB (7q34) gene break apart detection probe |
TCRB (7q34) |
IVD/RUO |
100μL/10 Tests |
|
Multiple Myeloma (MM) |
FP-021 |
RB1 gene deletion detection probe |
RB1 |
IVD/RUO |
100μL/10 Tests |
FP-014-2 |
CLL chromosome and gene anomaly detection probe |
P53/CEP17 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-242-3 |
BCL6 ; MYC ; IGH ; BCL2IGH gene detection probe |
IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-233-1 |
IGH/CCND1 ; IGH/MAF ; IGH/MAFB ; IGH/FGFR3 gene fusion detection probe |
CCND1/IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-025 |
13 (13q14) gene detection probe |
D13S319/LAMP1 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-197 |
1q21 and 1p32 anomaly detection probe |
1q21 and 1p32 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-233-2 |
IGH/CCND1 ; IGH/MAF ; IGH/MAFB ; IGH/FGFR3 gene fusion detection probe |
MAF/IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-234-2 |
MAFB/IGH ; CCND3/IGH ; MYC/IGH gene fusion detection probe |
CCND3/IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-233-4 |
IGH/CCND1 ; IGH/MAF ; IGH/MAFB ; IGH/FGFR3] gene fusion detection probe |
FGFR3/IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-233-3 |
GH/CCND1 ; IGH/MAF ; IGH/MAFB ; IGH/FGFR3 gene fusion detection probe |
MAFB/IGH |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-195 |
15q22 and 6q21 anomaly detection probe |
15q22/6q21 |
IVD/RUO |
100μL/10 Tests |
|
FP-200 |
D13S319 gene deletion detection probe |
D13S319 |
IVD/RUO |
100μL/10 Tests |
|
Myelodysplastic Syndrome (MDS) |
FP-011-1 |
MDS chromosome and gene anomaly detection probe |
D7S486/CEP7 |
CE-IVD/RUO |
100μL/10 Tests |
FP-011-2 |
D7S522/CEP7 |
CE-IVD/RUO |
100μL/10 Tests |
||
FP-011-3 |
CSF1R/D5S630 |
CE-IVD/RUO |
100μL/10 Tests |
||
FP-011-4 |
EGR1/D5S630 |
CE-IVD/RUO |
100μL/10 Tests |
||
FP-011-5 |
D20S108/CEP8 |
CE-IVD/RUO |
100μL/10 Tests |
||
FP-011-6 |
CEPX/CEPY |
CE-IVD/RUO |
100μL/10 Tests |
||
FP-018 |
Chromosome 8 centromere detection probe |
CEP8 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-230-3 |
PDGFRB gene break apart detection probe |
PDGFRB |
IVD/RUO |
100μL/10 Tests |
|
FP-200 |
D13S319 gene deletion detection probe |
D13S319 |
IVD/RUO |
100μL/10 Tests |
|
FP-305 |
13q gene detection probe |
RB1/13q34 |
CE-IVD/RUO |
100μL/10 Tests |
|
Aplastic Anemia |
FP-018 |
Chromosome 8 centromeric detection probe |
CEP8 |
CE-IVD/RUO |
100μL/10 Tests |
FP-011-1 |
MDS chromosome and gene anomaly detection probe |
D7S486/CEP7 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-011-4 |
MDS chromosome and gene anomaly detection probe |
EGR1/D5S630 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-020 |
20q gene deletion detection probe |
20q12/20q13.12 |
CE-IVD/RUO |
100μL/10 Tests |
|
Soft Tissue Cancer |
FP-055 |
SS18(SYT) gene break apart detection probe |
SS18(SYT) |
IVD/RUO |
100μL/10 Tests |
FP-054 |
MDM2 gene amplification detection probe |
MDM2 |
CE-IVD/RUO |
100μL/10 Tests |
|
FP-149 |
CDK4 (12q13)/SE12 detection probe |
CDK4/CEP12 |
IVD/RUO |
100μL/10 Tests |
|
FP-297 |
NR4A3(9q22) gene break apart detection probe |
NR4A3 |
IVD/RUO |
100μL/10 Tests |
|
Ph. Like ALL |
FP-141 |
CSF1R(5q32) gene break apart detection probe |
CSF1R |
IVD/RUO |
100μL/10 Tests |
FP-188 |
ABL1(9q34) gene break apart detection probe |
ABL1 |
IVD/RUO |
100μL/10 Tests |
|
FP-189 |
ABL2(1q25) gene break apart detection probe |
ABL2 |
IVD/RUO |
100μL/10 Tests |
|
FP-230-5 |
ABL1 ; ABL2 ; PDGFRB ; CRLF2 ; JAK2 gene break apart detection probe |
JAK2 |
IVD/RUO |
100μL/10 Tests |
|
Central Nervous System Tumor |
FP-048 |
MYCN gene amplification detection probe |
N-MYC/LAF4 |
IVD/RUO |
100μL/10 Tests |
FP-108 |
Chromosome 7 centromeric detection probe |
CEP7 (Green) |
IVD/RUO |
100μL/10 Tests |
|
Peripheral Nerve Tissue Tumor |
FP-050 |
SRD(1p36) gene deletion detection probe |
SRD/PBX1 |
IVD/RUO |
100μL/10 Tests |
Prenatal Diagnosis and Postnatal Examination |
FP-314 |
Prenatal chromosomes detection probe |
13/21 ; 18/X/Y |
CE-IVD/RUO |
200μL/10 Tests |
Non-Hodgkin Lymphoma |
FP-240 |
BCL6/IGH gene fusion t(3;14) detection probe |
BCL6/IGH |
IVD/RUO |
100μL/10 Tests |
Acute Myeloid Leukemia /AML |
FP-200 |
D13S319 gene deletion detection probe |
D13S319 |
IVD/RUO |
100μL/10 Tests |
FP-230-3 |
ABL1 ; ABL2 ; PDGFRB ; CRLF2 ; JAK2 gene break apart detection probe |
PDGFRB |
IVD/RUO |
100μL/10 Tests |
|
FP-305 |
13q gene detection probe |
RB1/13q34 |
CE-IVD/RUO |
100μL/10 Tests |
|
Prostate Cancer |
FP-307 |
TMPRSS2 gene break apart detection probe |
TMPRSS2 |
IVD/RUO |
100μL/10 Tests |
Kidney & Vascular Tumor |
FP-075 |
TFE3 gene break apart detection probe |
TFE3 |
IVD/RUO |
100μL/10 Tests |
Cartilage Tumor |
FP-149 |
CDK4(12q13)/SE12 detection probe |
CDK4/CEP12 |
IVD/RUO |
100μL/10 Tests |
Myeloproliferative Disease |
FP-305 |
13q gene detection probe |
RB1/13q34 |
CE-IVD/RUO |
100μL/10 Tests |
Extraskeletal Myxoid Chondrosarcoma (EMC) |
FP-297 |
NR4A3(9q22) gene break apart detection probe |
NR4A3 |
IVD/RUO |
100μL/10 Tests |
Fibroblast/ Myofibroblastic Tumor |
FP-181 |
ETV6 gene break apart detection probe |
ETV6 |
IVD/RUO |
100μL/10 Tests |
FP-074 |
USP6(17p13) gene break apart detection probe |
USP6 |
IVD/RUO |
100μL/10 Tests |
|
FP-053 |
FUS gene break apart detection probe |
FUS |
IVD/RUO |
100μL/10 Tests |
|
FP-051 |
EWSR1 gene break apart detection probe |
EWSR1 |
IVD/RUO |
100μL/10 Tests |
|
Striated muscle tumor |
FP-056 |
FKHR gene break apart detection probe |
FKHR |
IVD/RUO |
100μL/10 Tests |
(Rhabdomyoma) | FP-144 | PAX3(2q36) gene break apart detection probe | PAX3 | IVD/RUO | 100μL/10 Tests |
Thyroid | FP-059 | RET gene break apart detection probe | RET | IVD/RUO | 100μL/10 Tests |
Fibrohistiocytoma | FP-052 | DDIT3(CHOP) gene break apart detection probe | DDIT3 (CHOP) | IVD/RUO | 100μL/10 Tests |
Renal Cell Carcinoma (RCC) | FP-105 | 3p gene detection probe | 3p25/CEP3 | IVD/RUO | 100μL/10 Tests |
Plasma Cell Myeloma (PCM) | FP-207 | 20q gene detection probe | D20S108 | IVD/RUO | 100μL/10 Tests |
Endometrial Stromal Tumor (EST)/Endometrial Cancer |
FP-226 | JAZF1(7p15) gene break apart detection probe | JAZF1 | IVD/RUO | 100μL/10 Tests |
Human Genotyping Real-Time PCR Kits List |
||||||
Diagnosis |
Cat. # |
Description |
Name |
Volume/Size |
||
Warfarin Personalized Medicine |
RP-001 |
Human VKORC1 and CYP2C9 genes polymorphism detection kit |
VKORC1 gene -1639 mutation site; CYP2C9 gene *1,*2 and *3 gene variants |
12 Tests |
||
Clopidogrel Personalized Medicine |
RP-002 |
Human CYP2C19 gene polymorphism detection kit |
*1,*2,*3 and *17 gene variants |
12 Tests |
||
Statins Personalized Medicine |
RP-005 |
Human APOE gene polymorphism detection kit |
APOE gene E2, E3 and E4 gene variants |
20 Tests |
||
Nitroglycerin/Alcohol metabolic ability Personalized Medicine |
RP-003 |
Human ALDH2 gene polymorphism detection kit |
ALDH2 gene *1 and *2 gene variants |
20 Tests |
||
Folic acid supplementation dosage Personalized Medicine |
RP-004 |
Human MTHFR gene polymorphism detection kit |
MTHFR gene 677, 1298, 66 mutation sites |
20 Tests |
||
Aspirin Personalized Medicine |
RP-006 |
Human GPIIIa, GP1BAand PEAR1 genes polymorphism detection kit |
GP IIIa PlA2,PEAR1 and GP1BA gene variants |
20 Tests |
||
Predict the risk of liver fibrosis and liver cancer |
RP-007 |
Human TNF-αgenes polymorphism detection kit |
TNF-α gene variants |
20 Tests |
||
Asthma risk assessment |
RP-008 |
Human CYSLTR1and GSDML genes polymorphism detection kit |
CYSLTR1 and GSDML gene variants |
20 Tests |
||
Predict Risk of venous thrombosis |
RP-009 |
Human F5and PAI-1 genes polymorphism detection kit |
PAI-1 and F5 gene variants |
20 Tests |
||
FISH Pretreatment Reagent Kit & Instruments |
||||||
Product |
Cat. # |
Name |
Supply Format |
Volume/Size |
||
Laboratory FISH Routine Reagents |
CL-003/10 |
FISH Pretreatment Reagent Kit |
CE-IVD/RUO |
| ||
CL-004 |
In Situ Hybridization Staining Solution (Antifade DAPI) |
CE-IVD/RUO |
|
|||
Laboratory FISH Routine Apparatus |
TL101 |
FISH Slides Automatic Pretreatment Instrument |
CE-EMC |
Console |
Официальным дистрибьютором Wuhan HealthCare Biotechnology в России является компания «Микротесты б.м.в».